In the treated group, the LIVP-RFP cytokine analysis suggested elevation of CXCL10 in the tumor samples and IFN-α, IFN-γ, CCL2, CCL3, CXCL9, and CXCL10 in the sera samples. This evidence concerns the gene CCL2 and neoplasm.